LTF and glioblastoma: A new delivery platform, Lf-USLPs, has been created by conjugating lactoferrin to ultra-small sized, large-pored silica nanoparticles (USLPs) to deliver doxorubicin (DOX), which cannot penetrate the BBB, for glioblastoma treatment [18].